STOCK TITAN

Repare Therapeutics to Participate in Two Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Repare Therapeutics Inc. (Nasdaq: RPTX) announced participation in two virtual investor conferences in November 2021. The Northland Synthetic Lethality Investor Conference will take place on November 17 at 9:30 a.m. ET, with a live webcast available on the company's website. The Piper Sandler Healthcare Conference is scheduled from November 29 to December 2, with a prerecorded fireside chat available starting November 22 at 10 a.m. ET. Both events will have replays available for 90 days.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced that members of its senior management team will participate in two virtual investor conferences in November. Details are as follows:

Northland Synthetic Lethality Investor Conference
Date: Wednesday, November 17, 2021
Time: 9:30 a.m. Eastern Time

Piper Sandler Healthcare Conference
Date: Monday, November 29Thursday, December 2, 2021

A live webcast of the Northland Synthetic Lethality Investor Conference panel discussions will be available starting Wednesday, November 17, 2021 at 9:30 a.m. Eastern Time in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Company’s website for 90 days.

The prerecorded Piper Sandler Healthcare Conference fireside chat will be available on Monday, November 22, 2021 at 10 a.m. Eastern Time in the Investor section of the Company’s website at https://ir.reparerx.com/news-and-events/events. A replay of the webcast will be archived on the Company’s website for 90 days.

About Repare Therapeutics, Inc.

Repare Therapeutics is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor currently in Phase 1/2 clinical development, its second clinical candidate, RP-6306, a PKMYT1 inhibitor currently in Phase 1 clinical development, a Polθ inhibitor program, as well as eight other early-stage, pre-clinical programs. For more information, please visit reparerx.com.

SNIPRx® is a registered trademark of Repare Therapeutics Inc.

Repare:

Steve Forte

Chief Financial Officer

Repare Therapeutics Inc.

info@reparerx.com

Investors:

Kimberly Minarovich

Argot Partners

repare@argotpartners.com

Media:

David Rosen

Argot Partners

david.rosen@argotpartners.com

212-600-1902

Source: Repare Therapeutics Inc.

FAQ

When is the Northland Synthetic Lethality Investor Conference for RPTX?

The Northland Synthetic Lethality Investor Conference for Repare Therapeutics (RPTX) is on November 17, 2021, at 9:30 a.m. Eastern Time.

What date will the Piper Sandler Healthcare Conference for RPTX take place?

The Piper Sandler Healthcare Conference for Repare Therapeutics (RPTX) will occur from November 29 to December 2, 2021.

How can I access the webcasts for the RPTX investor conferences?

Webcasts for the RPTX investor conferences can be accessed on the Investor section of Repare Therapeutics' website.

When will the replay of the Piper Sandler Healthcare Conference be available for RPTX?

The replay of the Piper Sandler Healthcare Conference for Repare Therapeutics (RPTX) will be available starting on November 22, 2021, at 10 a.m. Eastern Time.

What is the ticker symbol for Repare Therapeutics?

The ticker symbol for Repare Therapeutics is RPTX, listed on NASDAQ.

Repare Therapeutics Inc. Common Shares

NASDAQ:RPTX

RPTX Rankings

RPTX Latest News

RPTX Stock Data

147.92M
42.45M
0.96%
87.24%
1.75%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAINT-LAURENT